BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Diabetes mellitus
,
Leukocyte
,
Hematopoietic cell
,
Phenobarbital
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
env
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Human plasmocytoid dendritic cells treated with HIV-1 matrix protein p17 or CpG
Dorsal root ganglia from rats modeling neuropathic pain by treatment with gp120 with ddC
PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for env
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Vol…
A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya
Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered Wit…
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ